Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2025 | Story Tshepo Tsotetsi | Photo Dr Reabetswe Parkies
BAccHons and PGDip graduates
Prof Frans Prinsloo, Head of the UFS School of Accountancy, with some of the proud 2024 BAccHons and PGDip (Chartered Accountancy) graduates who contributed to the School’s outstanding 96% pass rate in the June 2025 Initial Assessment of Competence (IAC).

The University of the Free State (UFS) has once again affirmed its position as one of the country’s leading institutions in accounting education. In the June 2025 Initial Assessment of Competence (IAC) by the South African Institute of Chartered Accountants (SAICA), UFS graduates from the 2024 BAccHons and PGDip (Chartered Accountancy) programmes achieved an exceptional 96% pass rate. This performance stands well above the national throughput of 76% across both the January and June sittings, confirming the university’s reputation for producing work-ready Chartered Accountants (CAs).

This achievement in the IAC – previously known as the Initial Test of Competence (ITC) – not only showcases the quality of teaching and learning at UFS but also echoes the recent SAICA endorsement visit, during which evaluators commended the School of Accountancy for cultivating confident, competent graduates ready to contribute to both the profession and the South African economy.

 

Driving excellence through vision and innovation

Reflecting on the results, Prof Frans Prinsloo, Head of the School of Accountancy, emphasised that this success confirms the School’s long-standing commitment to excellence and innovation. “Exceeding the national average by such a significant margin reinforces that our programmes are developing highly competent and sought-after Chartered Accountants. This achievement places UFS among the leading institutions in South Africa for producing high-quality graduates,” he said.

Prof Prinsloo attributed the outcome to the unwavering dedication of staff who, as highlighted by SAICA’s endorsement team, “go above and beyond” to support student success. He also pointed to a range of initiatives that have created an enabling environment for achievement, from a humanising pedagogy that prioritises student voices and dynamic learning communities, to early intervention strategies and an academic trainee programme that provides peer support through consultations and small-group sessions. “We are not just delivering a curriculum; w are fostering a culture of learning, growth, and achievement,” Prof Prinsloo added.

Prof Phillipe Burger, Dean of the Faculty of Economic and Management Sciences, said the results reflect the faculty’s broader vision of preparing leaders who can excel in both business and society. “We are preparing leaders for tomorrow, and education is the key to that. Corporate leadership requires technical expertise, but also resilience, adaptability, and the ability to work as part of a team. All of this we pack into our CA programme,” he explained.

Prof Burger also highlighted the faculty’s national role in shaping the profession through ongoing collaboration with SAICA and industry, ensuring that graduates remain relevant and highly employable. He noted the remarkable growth in the faculty’s accounting programmes, with the BAcc enrolling four times as many new first-year students this year compared to five years ago, alongside a significant increase in the average Admission Point (AP) scores of incoming students. “This growth, combined with rising admission standards, is testament to the quality of our programmes and the confidence that students and parents have in what we offer,” Prof Burger said.

As UFS celebrates this milestone, both leaders agree that the achievement belongs not only to the graduates but to the entire learning community. The outstanding 96% pass rate signals the university’s continued success in producing Chartered Accountants who are academically excellent, ethically grounded, and ready to make an impact in South Africa and beyond.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk.
Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept